The universal health challenge of highlighting drug safety by protecting the public confidence has become progressively more intricate. Drug discovery companies are forced to employ dedicated staff to take the responsibility for pharmacovigilance. Regulatory authorities are destined to weigh scale of probable benefits of novel drugs with unreliable levels of distrust of their latent harm.
Diploma in Pharmacovigilance & Pharmacoepidemiology will help to understand, how to critically evaluate the risks and benefits of novel drugs for human use including the reason, manifestation and effects of adverse drug effects (ADEs), the way of which these are discovered and monitored, and the related narrations along with legal bindings. The courses should throw light on fundamental of epidemiological, economic and statistical methods and concepts. Importance of pharmacoepidemiological methods and concepts and how these methods can be used to specific drug related and risk management issues will be taught.
Diploma in Pharmacovigilance & Pharmacoepidemiology helps in evaluating and decisively analyzing the outcomes of pharmacoepidemiological studies along with critical assessment of the study objective, study methods and conduct, design, statistical analyses and elucidation.
The post graduate or professional diploma in pharmacovigilance & pharmacoepidemiology courses offered by James Lind Institute will best suit for fresh graduates and experienced professionals working in medical, biotech, pharma and clinical research sectors.
*Written by Guest Author*